The NAD+ 1000mg & Retatrutide: A UK Breakthrough in Physiological Health
Emerging research from the UK are generating considerable buzz surrounding the potential synergy of high-dose NAD+ supplementation (1000mg) and the novel GLP-1 receptor agonist, Retatrutide. This unusual approach aims to address multiple facets of metabolic dysfunction , potentially offering a si